Last updated 14 days ago

A Clinical Study of V940 Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

1089 patients around the world
Available in Spain, Chile, Argentina
Merck Sharp & Dohme LLC
9Research sites
1089Patients around the world
This study is for people with
Skin cancer
Melanoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Clínica Adventista Belgrano - CABA - Buenos Aires
Clínica Adventista Belgrano - CABA - Buenos Aires
Recruiting
Estomba 1710, CABA, Buenos Aires
Hospital Alemán
Recruiting
Av. Pueyrredón 1640, CABA, Buenos Aires
Instituto Médico Especializado Alexander Fleming - CABA, Buenos Aires
Recruiting
Av. Crámer 1180, CABA, Buenos Aires
Centro Privado de RMI Río Cuarto
Recruiting
CGI, Pedernera 459, X5800CGI Río Cuarto, Córdoba, Argentina
Sanatorio Finochietto
Recruiting
Av. Córdoba 2678, C1187 CABA
Hospital Italiano de Buenos Aires - CABA, Buenos Aires
Recruiting
Juan Domingo Perón 4190, Piso 1, Ciudad Autónoma de Buenos Aires, C1181ACH
Centro de Investigación Clínica Bradford Hill - Santiago, Región Metropolitana
Centro de Investigación Clínica Bradford Hill - Santiago, Región Metropolitana
Recruiting
Manzano 343, Recoleta, Región Metropolitana, Santiago
Clínica San Carlos de Apoquindo - Red de Salud UC Christus
Recruiting
Camino El Alba 12407, Las Condes, Santiago
Instituto Oncológico FALP - UIDO
Recruiting
José Manuel Infante 805, Providencia, Región Metropolitana
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy